LIFE SCIENCES

Excess Liability

Target classes


  • Biotechnology
  • Clinical trials
  • Contract manufacturers
  • Contract research organizations
  • Life sciences service organizations
  • Medical devices
  • Pharmaceuticals
  • Research and development

Excess Liability Coverage


Supporting excess over:

  • Product Liability
  • Professional Liability
  • General Liability
  • Medical Professional Liability

Straight line capacity, quota share, and ventilated options available.

Key features


  • Customized and bespoke underwriting options available
  • Straightforward follow-form policy language
  • Defense expense provided within the limits of insurance
  • Erosion recognition for prior underlying retro dates
  • Partial payment of loss language
  • No size of risk minimum or maximum

Product information is for descriptive purposes only and does not provide a complete summary of coverage and is intended for use by licensed insurance producers. It is not an offer to sell, or a solicitation to buy, any insurance product for a particular insured. Policy terms, conditions or exclusions may vary. Coverage may not be available in all jurisdictions and is subject to underwriting. Consult the applicable insurance policy for specific terms, conditions, limits, limitations, and exclusions. No insurance product is offered or will be sold in any jurisdiction in which such offer or solicitation would be unlawful. More information about AXIS’ financial strength and individual insurance company ratings is available here. Some products may be offered by AXIS companies not admitted in certain states, and therefore may be available only through licensed surplus lines brokers. These products may be underwritten by AXIS Surplus Insurance Company (NAIC # 26620), an Illinois domestic surplus lines insurance company. Surplus lines insurers do not generally participate in state guaranty funds, and insureds are not protected by such funds.

Cookies | Terms | Privacy | Print | 11.6.2025

Cookies | Terms | Privacy | Print | 2.13.2025

Cookies | Terms | Privacy | Print | 3.6.2025